BACKGROUND: Monoclonal antibodies (MAbs) can be used to detect, image and treat cancers. This study aimed to characterise the binding of BLCA-38 MAbs to human prostate cancer cell lines, human prostate cancer biopsy samples and normal tissues to enable future targeted studies. METHODS: BLCA-38 antigen expression on cancer lines was determined by flow cytometry; that on patient specimens from normal tissues and cancers was tested by immunohistochemistry using fresh frozen tissues or paraffin-embedded tissues that had undergone antigen retrieval. RESULTS: Cell surface BLCA-38 antigen expression was seen on DU-145, PC-3, PC-3 M and PC-3 M-MM2 prostate cancer lines, but LNCaP, MDA PCa 2a or MDA PCa 2b lines were negative. Other human lines, including 8/12 bladder cancer and A431 vulval epidermoid cells, but not breast cancer lines, expressed BLCA-38 antigen. Staining occurred in glandular epithelial cells in the majority of frozen, and paraffin-embedded prostate cancer tissues and was occasionally seen in prostatic intraepithelial neoplasia (PIN). No staining was observed in normal cadaver tissues or in benign areas from various other cancer tissues. CONCLUSIONS: The BLCA-38 antibody binds to the majority of human prostate cancers but not to normal cells, and has potential for targeting novel therapies in patients with this disease.
BACKGROUND: Monoclonal antibodies (MAbs) can be used to detect, image and treat cancers. This study aimed to characterise the binding of BLCA-38 MAbs to humanprostate cancer cell lines, humanprostate cancer biopsy samples and normal tissues to enable future targeted studies. METHODS: BLCA-38 antigen expression on cancer lines was determined by flow cytometry; that on patient specimens from normal tissues and cancers was tested by immunohistochemistry using fresh frozen tissues or paraffin-embedded tissues that had undergone antigen retrieval. RESULTS: Cell surface BLCA-38 antigen expression was seen on DU-145, PC-3, PC-3 M and PC-3 M-MM2 prostate cancer lines, but LNCaP, MDA PCa 2a or MDA PCa 2b lines were negative. Other human lines, including 8/12 bladder cancer and A431 vulval epidermoid cells, but not breast cancer lines, expressed BLCA-38 antigen. Staining occurred in glandular epithelial cells in the majority of frozen, and paraffin-embedded prostate cancer tissues and was occasionally seen in prostatic intraepithelial neoplasia (PIN). No staining was observed in normal cadaver tissues or in benign areas from various other cancer tissues. CONCLUSIONS: The BLCA-38 antibody binds to the majority of humanprostate cancers but not to normal cells, and has potential for targeting novel therapies in patients with this disease.
Authors: Yu Shi; Bingyang Shi; Arun V Everest Dass; Yiqing Lu; Nima Sayyadi; Liisa Kautto; Robert D Willows; Roger Chung; James Piper; Helena Nevalainen; Bradley Walsh; Dayong Jin; Nicolle H Packer Journal: Sci Rep Date: 2016-11-22 Impact factor: 4.379
Authors: Rachel A Levin; Maria E Lund; Quach Truong; Angela Wu; Neal D Shore; Daniel R Saltzstein; Raoul S Concepcion; Thomas A Paivanas; Arletta van Breda; Jennifer Beebe-Dimmer; Julie J Ruterbusch; Sandra Wissmueller; Douglas H Campbell; Bradley J Walsh Journal: Oncotarget Date: 2018-04-27
Authors: Douglas H Campbell; Maria E Lund; Aline L Nocon; Paul J Cozzi; Mark Frydenberg; Paul De Souza; Belinda Schiller; Jennifer L Beebe-Dimmer; Julie J Ruterbusch; Bradley J Walsh Journal: PLoS One Date: 2018-04-19 Impact factor: 3.240
Authors: Mei-Chun Yeh; Brian W C Tse; Nicholas L Fletcher; Zachary H Houston; Maria Lund; Marianna Volpert; Chelsea Stewart; Kamil A Sokolowski; Varinder Jeet; Kristofer J Thurecht; Douglas H Campbell; Bradley J Walsh; Colleen C Nelson; Pamela J Russell Journal: EJNMMI Res Date: 2020-05-07 Impact factor: 3.138
Authors: Dmitry M Polikarpov; Douglas H Campbell; Lucinda S McRobb; Jiehua Wu; Maria E Lund; Yanling Lu; Sergey M Deyev; Andrew S Davidson; Bradley J Walsh; Andrei V Zvyagin; David A Gillatt Journal: Cancers (Basel) Date: 2020-04-16 Impact factor: 6.639
Authors: Maria E Lund; Christopher B Howard; Kristofer J Thurecht; Douglas H Campbell; Stephen M Mahler; Bradley J Walsh Journal: BMC Cancer Date: 2020-12-10 Impact factor: 4.430
Authors: Dhanusha Sabanathan; Douglas H Campbell; Vicki M Velonas; Sandra Wissmueller; Hubert Mazure; Marko Trifunovic; Pirooz Poursoltan; Kevin Ho Shon; Tiffany R Mackay; Maria E Lund; Yanling Lu; Paul J Roach; Dale L Bailey; Bradley J Walsh; David Gillatt; Howard Gurney Journal: Asia Ocean J Nucl Med Biol Date: 2021
Authors: Quach Truong; Irene O Justiniano; Aline L Nocon; Julie T Soon; Sandra Wissmueller; Douglas H Campbell; Bradley J Walsh Journal: J Cancer Date: 2016-05-21 Impact factor: 4.207